The G-Rex Grant Program is HERE!!
The G-Rex® Grant Program is a $20 million initiative by ScaleReady, Wilson Wolf Manufacturing, Bio-Techne, and CellReady, that is designed to propel the advancement of cell and gene therapies (CGT).
Download the Program Outline PDF HERE
Maintain high cell quality from research bench to clinical bedside.
Cell phenotype drift during scale-up is avoidable. G-Rex bioreactors, combined with high-quality reagents, maintain cell phenotype profiles across small and large scale expansion.
GMP raw materials for any process at any scale.
Raw material quality, supply, and process fit won’t be an issue. ScaleReady’s adaptable workflow, flexible filling, and supply agreements for GMP reagents ensure process customization and supply security as you scale.
Latest ScaleReady news and events.
IBTV: Advanced Therapies Week 2025
Pharma's Almanac: How is the pharmaceutical industry integrating innovations from adjacent industries
BioXconomy: The sustainability series: Reflect, rethink, and reform
Get in touch to begin scaling up and scaling out.
Let’s talk more about how ScaleReady can advance your cell and gene therapy research and manufacturing with ingenious efficiency.